Jeffrey Statland

Associate Professor of Neurology at Kansas University Medical Center and Director of KUMC MDA Clinics · University of Rochester Medicine

Credentials: · · · ·

History

Rare Disease Network for Myasthenia Gravis
National Institute of Neurological Disorders and Stroke · U54
Project lead · $222.3K · George Washington University
2019–2030
Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $3.4M · University of Kansas Medical Center
2024–2029
RFA-TS-22-001:Towards Better Understanding of ALS Using a Multi-Marker Discovery Approach from a Multi-Modal Database (ALS4M)
ATSDR · R01
PI · $895.2K · University of Missouri-Columbia
2022–2025
Development and Validation of Clinical Outcome Assessments in LGMD2A
National Center for Advancing Translational Sciences · R21
PI · $452.4K · Virginia Commonwealth University
2020–2024

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
Principal investigator · Recruiting
University of Kansas Medical Center
2025–2028
A Study of Ranolazine in ALS
Principal investigator · Recruiting · Phase 2
Swathy Chandrashekhar, MBBS
2025–2028
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Principal investigator · Recruiting
University of Kansas Medical Center
2020–2028
Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
Principal investigator · Completed · Phase 2
University of Kansas Medical Center
2018–2022